Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01300000
Other study ID # AK65
Secondary ID
Status Completed
Phase N/A
First received February 17, 2011
Last updated March 27, 2017
Start date March 2010
Est. completion date August 2016

Study information

Verified date March 2017
Source Abbott Nutrition
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The primary objective of the study is to compare the growth of infants fed standard infant formula with infants fed a reduced calorie and protein formula.


Recruitment information / eligibility

Status Completed
Enrollment 649
Est. completion date August 2016
Est. primary completion date September 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A to 24 Hours
Eligibility Inclusion Criteria:

- good health

- singleton birth with gestational age 37-42 weeks

- infant's birth weight >or = to 2500 grams

- exclusive breastfeeding or exclusively formula feeding

- within a defined geographical boundary

- mother has no problems communicating in English

Exclusion Criteria:

- adverse maternal, fetal or infant medical history

- congenital disease or malformation affecting growth or development

- illness or social problems in mother or infant

- temporary residents

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Human Milk
ad lib
Investigational infant formula
ad lib
Milk based standard infant formula
ad lib

Locations

Country Name City State
United Kingdom MRC Childhood Nutrition Research Center, Institute of Child Health London

Sponsors (2)

Lead Sponsor Collaborator
Abbott Nutrition Institute of Child Health

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Other Vascular at 24 months
Other Maternal Anthropometrics at 24 months
Primary Weight gain 1- 365 days
Secondary Gastrointestinal tolerance 1-365 days
Secondary Infant Anthropometrics 1 - 365 days; 24 months
See also
  Status Clinical Trial Phase
Completed NCT01380886 - Growth and Tolerance of Young Infants Fed Infant Formulas Phase 3